GARIN2
Golgi-associated RAB2 interactor protein 2
Also known as: C14orf54, FAM71D, GAR2_HUMAN, GARI-L2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N9W8
- Gene
- GARIN2
- Ensembl
- ENSG00000172717
- Chromosome
- 14
- Canonical length
- 422 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Predicted to be involved in flagellated sperm motility. Predicted to act upstream of or within cell morphogenesis; penetration of zona pellucida; and spermatid development. Predicted to be located in sperm midpiece. Predicted to be active in sperm head. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
422 residues, UniProt reviewed canonical sequence.
>Q8N9W8|GARIN2
1 MKKNTSKTTM RINKQDALCT PHSHDPRDLQ NMLDGGEYAP FVSPPMLESN FIQVNRRGES
61 IYLHNRANWV TVGICFSSST HKIPNVMLLA HLTPGAQKDT ETLFKSLLTS PPAEKLVLTR
121 FLPLQFVTLS VHDAENMSLK VKLVSGRAYY LQLCTSAYKQ DTLFSQWVAL ISLLNQEKAK
181 VSKVSEVSSL SGITNSTDIT GSMDVTDVTT FTAILTPYMY AGTGPEHVRD SIDFPEFTDI
241 TDITDVTDLP ENEVPEVPDV RIVTEVIEVR EATEVTDSSD ITNCSGVTVV FENNDLIRAK
301 QEEKEKLKNI LKPGCLQDTK SKSELKESSK HVTISNITLT FEGKRYFQTT LTPVESEANT
361 SKEMKDKTSE EKMPDFQSTA LKAEESRSLR TESNTSVLSP HIKSPSNFLK LVPHLSAPFS
421 RELocalizationUniProt · AlphaFold · HPA
Whether an antibody against GARIN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- testis: 22 nTPM
- retina: 0.8 nTPM
- skin: 0.3 nTPM
- duodenum: 0.2 nTPM
- epididymis: 0.2 nTPM
- heart muscle: 0.2 nTPM
Single-cell type
- late spermatids: 432 nCPM
- early spermatids: 312 nCPM
- late primary spermatocytes: 53 nCPM
- cardiomyocytes: 17 nCPM
- rod photoreceptor cells: 9.9 nCPM
- epicardial cells: 9.1 nCPM
Immune cell
- plasmacytoid DC: 0.2 nTPM
- gdT-cell: 0.1 nTPM
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebellum: 4.6 nTPM
- cerebral cortex: 3.4 nTPM
- hypothalamus: 3.4 nTPM
- white matter: 3.4 nTPM
- basal ganglia: 2.6 nTPM
- pons: 2.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- DepMap mean gene effect
- 0.15
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GARIN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GARIN2 as an antibody target. Whether an autoantibody or antibody against GARIN2 could matter depends on whether native GARIN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GARIN2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GARIN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...